Alzheimer's

Carolyn Gretton

The answer to reversing Alzheimer’s may already be on the pharmacy shelf

One reason Alzheimer’s disease is such a dreaded diagnosis is there’s no effective treatment to halt its progression. But one research team has found potential in medications that have been used for years to treat other conditions that appear to reverse it. But is the answer in the medications or the conditions themselves?

Dr. Adria Schmedthorst

The aluminum-Alzheimer’s connection grows stronger

Everyday items we come in contact with can impact our health. One of those is aluminum, long associated with breast cancer and Alzheimer’s. As a theory, it’s controversial, but researchers find it wrapped up in brain tau tangles. Do you know all the ways you’re exposed to it?

Dr. Adria Schmedthorst

Why a hospital stay could increase risk for Alzheimer’s and Parkinson’s

No one plans to get sick enough from a viral or bacterial infection to be hospitalized. But now there’s all the more reason to plan to avoid that scenario. That’s because landing in the hospital for infection just a couple of times could greatly impact the health of your brain a few years later…

Joyce Hollman

3-year study proves lipids keeps Alzheimer’s at bay

Of the 10 leading causes of death in the United States, including cancer, heart disease and diabetes, Alzheimer’s is the only disease where existing treatments don’t really help. But now, scientists are working on ways that nutrition can slow the cognitive decline and memory loss of Alzheimer’s. And lipids hold the key…

Dr. Adria Schmedthorst

More COVID fallout: More than double the Alzheimer’s risk

Because there’s no cure for Alzheimer’s, our only option to turn the tide is by reducing general risk factors. Working on lifestyle is manageable. But when a pandemic-related virus turns out to up the ante, the task may seem insurmountable, until you know the real trigger…

Carolyn Gretton

The antibody that could take down Alzheimer’s plaques

Alzheimer’s disease therapies leave a lot to be desired. But researchers are learning more about the mechanisms behind the disease and may have found a link to a whole new avenue of treatment… delivering antibody-based therapies across the blood-brain barrier.